Domestic da Vinci Xi surgical robot officially launched

On November 6, 2023, the domestically produced da Vinci Xi surgery was officially announced to be launched at the CIIE.

In 2006, the first imported da Vinci S surgical robot entered the General Hospital of the Chinese People's Liberation Army. In early 2007, with the efforts of the medical team, China's first fully robotic non-open-chest cardiac surgery was successfully completed, marking a new starting point for minimally invasive surgery with surgical medical robots in China.

17 years later, more than 400,000 patients in China have undergone da Vinci robot surgeries and returned to their daily lives. This year, the locally produced fourth-generation da Vinci Xi surgical robot was approved by the National Medical Products Administration, and Intuitive Fosun successfully achieved the localization of the da Vinci surgical robot.

This year marks the sixth consecutive year that Intuitive Fosun has participated in the CIIE. With the CIIE as a new starting point, the domestically produced da Vinci Xi surgical robot officially met the public for the first time, conveying Intuitive Fosun's unchanging commitment and confidence in the Chinese market. Leaders of the Shanghai Drug Administration, Brian Miller, Executive Vice President and Chief Digital Officer of Intuitive Healthcare, Darla Hutton, Vice President of Marketing and Commercial Operations for Asia Pacific at Intuitive Healthcare, Neeta Mhatre, Vice President of Operations and Strategy for China at Intuitive Healthcare, Pan Xiaofeng, CEO of Intuitive Fosun, Peng Honglan, Chief Commercial Officer of Intuitive Fosun, and guests from all walks of life attended the launch ceremony of the domestically produced da Vinci Xi surgical system and witnessed the official launch of the domestically produced da Vinci Xi surgical robot.

Dr. Brian Miller said in his speech: "Intuitive Fosun has been committed to serving Chinese patients, surgeons and healthcare systems. Today, our "flagship" innovative surgical system, the da Vinci Xi, is domestically produced in China and will be launched on the market. I am very happy to celebrate this major milestone. We believe that this domestically produced Xi surgical robot - together with our R&D, training and broader medical innovation ecosystem investment in China - will help meet the current and future needs for the best minimally invasive and robotic-assisted surgical technologies and treatments."

01

"Exhibits" become "

Accelerate the localization process

Fosun and the CIIE have worked together for six years to accelerate the promotion of accessibility to high-quality medical care.

Through the CIIE platform, Fosun has realized the transformation from star exhibits to high-quality products:

1

The imported da Vinci Xi surgical robot was exhibited at the first CIIE. After its debut at the CIIE, the da Vinci Xi surgical robot was officially launched in China, realizing the transformation from "imported exhibit" to "imported commodity". This year, Intuitive Fosun's thoracic and abdominal endoscopic surgery (domestic da Vinci Xi surgical robot) successfully passed the approval of the National Medical Products Administration, and the da Vinci Xi surgical robot was officially localized and became a domestic "commodity".

2

The Ion bronchoscope control system was unveiled at the CIIE in 2019. In 2022, Ion passed the review of the National Medical Products Administration and entered the green channel for medical device innovation approval.

3

The da Vinci SP robot was first exhibited at the CIIE in 2020. This year, the da Vinci SP robot surgery has successively completed the first real-world urology, otolaryngology and gynecology research in Boao.

Along the way, Intuitive Fosun is not only a participant and witness of the CIIE, but also a beneficiary of the value of the CIIE platform. With the powerful "spillover effect" of the CIIE, it has promoted the integrated innovation of the high-end medical equipment industry chain and supply chain, and through in-depth cooperation with various medical institutions, improved the ecosystem and demonstrated the higher technical value of products; promoted the implementation of innovative results, built more practical innovation platforms for surgeons, improved doctors' capabilities, and expanded the application of robot-assisted surgery; benefited the vast number of Chinese patients with innovation and high-quality services, and made the exhibits at the CIIE truly "enter" the hearts of patients.

02

Cutting-edge innovative scientific and technological achievements

Empowering a new future of precision medicine

At the CIIE, Intuitive Fosun fully demonstrated its innovative precision medical products and forward-looking concepts, including the first domestically produced da Vinci Xi robot and Ion bronchoscope control system (not yet available in China).

Domestic Da Vinci Xi robot

The domestically produced Da Vinci Xi robot maintains the high quality of the original imported products.

• Possessing next generation software and, it enables high quality surgeries, has advanced instrument support and other features.

• Chinese interface and Chinese voice prompts.

At the CIIE, the domestically produced Da Vinci Xi robot attracted a large number of visitors to stop and watch. People from all walks of life came to the scene and immersively experienced the innovative application scenarios of medical robots.

Ion Bronchoscope Control System

(Not available in China)

Early diagnosis is crucial to improving the 5-year survival rate of lung cancer.

The Ion bronchoscope control system is a new type of arm-assisted bronchoscope operation control system. It can diagnose and treat peripheral lung nodules through the natural cavity. It helps to diagnose lung cancer early and improve the five-year survival rate of lung cancer patients.

The Ion bronchoscope control system is expected to be available on the market next year, serving more patients with the goal of greater precision, greater stability and fewer complications.

Through the CIIE platform, Intuitive Fosun continues to deepen its investment in local technology and strive to introduce innovative resources into China. In the future, Intuitive Fosun will continue to deepen its role in China's medical and health system, expand the popularization of cutting-edge technology and high-quality medical resources, promote the development of China's precision medicine industry, and build a healthy China.

Editor: Huang Fei